» Articles » PMID: 35252012

Circulating Tumor Cell Identification Based on Deep Learning

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Mar 7
PMID 35252012
Authors
Affiliations
Soon will be listed here.
Abstract

As a major reason for tumor metastasis, circulating tumor cell (CTC) is one of the critical biomarkers for cancer diagnosis and prognosis. On the one hand, CTC count is closely related to the prognosis of tumor patients; on the other hand, as a simple blood test with the advantages of safety, low cost and repeatability, CTC test has an important reference value in determining clinical results and studying the mechanism of drug resistance. However, the determination of CTC usually requires a big effort from pathologist and is also error-prone due to inexperience and fatigue. In this study, we developed a novel convolutional neural network (CNN) method to automatically detect CTCs in patients' peripheral blood based on immunofluorescence hybridization (imFISH) images. We collected the peripheral blood of 776 patients from Chifeng Municipal Hospital in China, and then used Cyttel to delete leukocytes and enrich CTCs. CTCs were identified by imFISH with CD45+, DAPI+ immunofluorescence staining and chromosome 8 centromeric probe (CEP8+). The sensitivity and specificity based on traditional CNN prediction were 95.3% and 91.7% respectively, and the sensitivity and specificity based on transfer learning were 97.2% and 94.0% respectively. The traditional CNN model and transfer learning method introduced in this paper can detect CTCs with high sensitivity, which has a certain clinical reference value for judging prognosis and diagnosing metastasis.

Citing Articles

Lessons (to be) learned from liquid biopsies: assessment of circulating cells and cell-free DNA in cancer and pregnancy-acquired microchimerism.

Bergmann L, Afflerbach A, Yuan T, Pantel K, Smit D Semin Immunopathol. 2025; 47(1):14.

PMID: 39893314 PMC: 11787191. DOI: 10.1007/s00281-025-01042-z.


CTCNet: a fine-grained classification network for fluorescence images of circulating tumor cells.

Wu J, Wang H, Nie Y, Wang Y, He W, Wang G Med Biol Eng Comput. 2025; .

PMID: 39841310 DOI: 10.1007/s11517-025-03297-y.


Improving Circulating Tumor Cell Detection Using Image Synthesis and Transformer Models in Cancer Diagnostics.

Liang S, Bai X, Gu Y Sensors (Basel). 2024; 24(23).

PMID: 39686359 PMC: 11644996. DOI: 10.3390/s24237822.


CACs Recognition of FISH Images Based on Adaptive Mean Teacher Semi-supervised Learning with Domain-Knowledge Pseudo Label.

Weng Y, Hu Q, Wang H, Kuang Y, Zhou Y, Tang Y J Imaging Inform Med. 2024; .

PMID: 39668308 DOI: 10.1007/s10278-024-01348-8.


A Hybrid Intelligence Approach for Circulating Tumor Cell Enumeration in Digital Pathology by Using CNN and Weak Annotations.

Tong L, Wan Y IEEE Access. 2024; 11:142992-143003.

PMID: 38957613 PMC: 11218908. DOI: 10.1109/access.2023.3343701.


References
1.
Le N, Huynh T, Yapp E, Yeh H . Identification of clathrin proteins by incorporating hyperparameter optimization in deep learning and PSSM profiles. Comput Methods Programs Biomed. 2019; 177:81-88. DOI: 10.1016/j.cmpb.2019.05.016. View

2.
Koudelakova V, Trojanec R, Vrbkova J, Donevska S, Bouchalova K, Kolar Z . Frequency of chromosome 17 polysomy in relation to CEP17 copy number in a large breast cancer cohort. Genes Chromosomes Cancer. 2016; 55(5):409-17. DOI: 10.1002/gcc.22337. View

3.
Keller L, Werner S, Pantel K . Biology and clinical relevance of EpCAM. Cell Stress. 2019; 3(6):165-180. PMC: 6558934. DOI: 10.15698/cst2019.06.188. View

4.
Tamminga M, Groen H, Hiltermann T . Investigating CTCs in NSCLC-a reaction to the study of Jia-Wei Wan: a preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer. J Thorac Dis. 2016; 8(6):1032-6. PMC: 4885991. DOI: 10.21037/jtd.2016.04.17. View

5.
Dong J, Zhu D, Tang X, Qiu X, Lu D, Li B . Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I-III Non-small Cell Lung Cancer Patients. Front Oncol. 2019; 9:1139. PMC: 6830362. DOI: 10.3389/fonc.2019.01139. View